Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    Amber Sarcone and her drive to succeed and beat chondrosarcoma.

    January 3rd, 2023

    Happy New Year!

    With the new year, the Chondrosarcoma Foundation is kicking-off the year by hosting and promoting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 32nd birthday). We ask that you join us in wearing a Yellow Ribbon or…

    Read Article

    Holiday Wishes and New Year Resolutions

    December 26th, 2022

    I would like to wish everyone the best for this holiday season. May you all cherish the moments you have with your family and blessings to you all for a Healthy and Happy New Year. I thank each and every one of you for the caring and support you…

    Read Article

    Chondrosarcoma Awareness Day Tribute to Parker Jeffrey Morgan

    December 17th, 2022

    With Chondrosarcoma Awareness Day: February 6, less than two months away, we want to share stories of our community / our family who provide us with inspiration. Some of our members lost their battle with Chondrosarcoma. Others are surviving,…

    Read Article

    February 6 is Chondrosarcoma Awareness Day

    December 10th, 2022

    International Chondrosarcoma Awareness Day

    February 6, 2023
    Wear A Yellow Ribbon / Wrist Band and Show Your Support
    for Chondrosarcoma Research and Clinical Trials

    As many of you are aware to honor my daughter who passed away from Grade 3…

    Read Article

    Poster Presentation regarding INBRX-109 at CTOS Conference on November 16-19

    November 28th, 2022

    Read Article

    INBRX-109 Phase 2 Clinical Trial to Treat Unresectable or Metastatic Conventional Chondrosarcoma


    Inhibrx has initiated a phase 2 clinical trial to treat unresectable or metastatic conventional chondrosarcoma. The poster was presented at the Connective Tissue Oncology Society (CTOS) in Vancouver, Canada from November 16-19.

    The results of the…

    Read Article

    INBRX-109 Phase 2 Study still looking for Patients

    November 23rd, 2022

    Inhibrx is recruiting for Chondrosarcoma patients to participate in their Phase 2 study of the medication. Presently there are 130 openings for the Phase 2 trial.

    Summary is listed below, for more…

    Read Article

    Inhibrx Announces Participation in Upcoming Scientific Conferences on INBRX-109

    October 24th, 2022

    SAN DIEGO, Oct. 20, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at multiple upcoming…

    Read Article

    Pictures from Steppin’ for a Cause

    October 21st, 2022

    Here are pictures from our event: Steppin’ for A Cause held on October 15, at Allen Pond in Bowie, Maryland. We had 50 people participate in our 5k Walk / Run and raised $3,200 ($500 more than last year).

    Thank you to everyone for your…

    Read Article

    Pictures of Ricky Ashman’s Sky Diving Adventure to Raise Money for the Chondrosarcoma Foundation

    October 11th, 2022

    Please enjoy the pictures of Ricky Ashman’s sky dive in Salisbury, United Kingdom. He raised over 1300 pounds for the Chondrosarcoma Foundation to honor his mother Harriet Stone who is a Chondrosarcoma Warrior. He jumped from 15,000 feet, flying at…

    Read Article
    Skip to content